位置:首页 > 蛋白库 > NEUR1_MOUSE
NEUR1_MOUSE
ID   NEUR1_MOUSE             Reviewed;         409 AA.
AC   O35657; O55220; Q99KG9;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   03-AUG-2022, entry version 182.
DE   RecName: Full=Sialidase-1;
DE            EC=3.2.1.18;
DE   AltName: Full=G9 sialidase;
DE   AltName: Full=Lysosomal sialidase;
DE   AltName: Full=N-acetyl-alpha-neuraminidase 1;
DE   Flags: Precursor;
GN   Name=Neu1; Synonyms=Neu;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, AND FUNCTION.
RC   STRAIN=C57BL/RIJ;
RX   PubMed=9363440; DOI=10.1093/glycob/7.7.975;
RA   Carrillo M.B., Milner C.M., Ball S.T., Snoek M., Campbell R.D.;
RT   "Cloning and characterization of a sialidase from the murine
RT   histocompatibility-2 complex: low levels of mRNA and a single amino acid
RT   mutation are responsible for reduced sialidase activity in mice carrying
RT   the Neu1a allele.";
RL   Glycobiology 7:975-986(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=9384611; DOI=10.1093/hmg/7.1.115;
RA   Igdoura S.A., Gafuik C., Mertineit C., Saberi F., Pshezhetsky A.V.,
RA   Potier M., Trasler J.M., Gravel R.A.;
RT   "Cloning of the cDNA and gene encoding mouse lysosomal sialidase and
RT   correction of sialidase deficiency in human sialidosis and mouse SM/J
RT   fibroblasts.";
RL   Hum. Mol. Genet. 7:115-121(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=129;
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D.,
RA   Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   VARIANT ILE-209.
RX   PubMed=9425240; DOI=10.1093/hmg/7.2.313;
RA   Rottier R.J., Bonten E.J., d'Azzo A.;
RT   "A point mutation in the neu-1 locus causes the neuraminidase defect in the
RT   SM/J mouse.";
RL   Hum. Mol. Genet. 7:313-321(1998).
CC   -!- FUNCTION: Catalyzes the removal of sialic acid (N-acetylneuraminic
CC       acid) moieties from glycoproteins and glycolipids. To be active, it is
CC       strictly dependent on its presence in the multienzyme complex. Appears
CC       to have a preference for alpha 2-3 and alpha 2-6 sialyl linkage.
CC       {ECO:0000269|PubMed:9363440, ECO:0000269|PubMed:9384611}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-
CC         (2->8)- glycosidic linkages of terminal sialic acid residues in
CC         oligosaccharides, glycoproteins, glycolipids, colominic acid and
CC         synthetic substrates.; EC=3.2.1.18;
CC         Evidence={ECO:0000269|PubMed:9363440, ECO:0000269|PubMed:9384611};
CC   -!- SUBUNIT: Interacts with cathepsin A (protective protein), beta-
CC       galactosidase and N-acetylgalactosamine-6-sulfate sulfatase in a
CC       multienzyme complex.
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:9384611};
CC       Peripheral membrane protein {ECO:0000269|PubMed:9384611}; Lumenal side
CC       {ECO:0000269|PubMed:9384611}. Lysosome lumen
CC       {ECO:0000269|PubMed:9384611}. Cell membrane
CC       {ECO:0000269|PubMed:9384611}. Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:9384611}. Note=Localized not only on the inner side
CC       of the lysosomal membrane and in the lysosomal lumen, but also on the
CC       plasma membrane and in intracellular vesicles.
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, epididymis, followed by
CC       brain, spinal cord and weakly expressed in adrenal, heart, liver, lung
CC       and spleen. {ECO:0000269|PubMed:9384611}.
CC   -!- DOMAIN: A C-terminal internalization signal (YGTL) appears to allow the
CC       targeting of plasma membrane proteins to endosomes.
CC   -!- PTM: N-glycosylated. {ECO:0000305}.
CC   -!- PTM: Phosphorylation of tyrosine within the internalization signal
CC       results in inhibition of sialidase internalization and blockage on the
CC       plasma membrane.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 33 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y11412; CAA72215.1; -; mRNA.
DR   EMBL; U93702; AAC53536.1; -; mRNA.
DR   EMBL; AF109906; AAC84167.1; -; Genomic_DNA.
DR   EMBL; BC004666; AAH04666.1; -; mRNA.
DR   CCDS; CCDS28668.1; -.
DR   RefSeq; NP_035023.3; NM_010893.3.
DR   AlphaFoldDB; O35657; -.
DR   SMR; O35657; -.
DR   BioGRID; 201731; 1.
DR   IntAct; O35657; 2.
DR   STRING; 10090.ENSMUSP00000007253; -.
DR   ChEMBL; CHEMBL4105926; -.
DR   CAZy; GH33; Glycoside Hydrolase Family 33.
DR   GlyConnect; 2710; 1 N-Linked glycan (1 site).
DR   GlyGen; O35657; 4 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; O35657; -.
DR   PhosphoSitePlus; O35657; -.
DR   SwissPalm; O35657; -.
DR   EPD; O35657; -.
DR   PaxDb; O35657; -.
DR   PeptideAtlas; O35657; -.
DR   PRIDE; O35657; -.
DR   ProteomicsDB; 287388; -.
DR   Antibodypedia; 51599; 387 antibodies from 26 providers.
DR   DNASU; 18010; -.
DR   Ensembl; ENSMUST00000007253; ENSMUSP00000007253; ENSMUSG00000007038.
DR   GeneID; 18010; -.
DR   KEGG; mmu:18010; -.
DR   UCSC; uc008cei.2; mouse.
DR   CTD; 4758; -.
DR   MGI; MGI:97305; Neu1.
DR   VEuPathDB; HostDB:ENSMUSG00000007038; -.
DR   eggNOG; ENOG502QSIT; Eukaryota.
DR   GeneTree; ENSGT00950000182944; -.
DR   HOGENOM; CLU_024620_3_0_1; -.
DR   InParanoid; O35657; -.
DR   OMA; WSPTEFI; -.
DR   OrthoDB; 652179at2759; -.
DR   PhylomeDB; O35657; -.
DR   TreeFam; TF331063; -.
DR   BRENDA; 3.2.1.18; 3474.
DR   Reactome; R-MMU-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-MMU-4085001; Sialic acid metabolism.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   BioGRID-ORCS; 18010; 3 hits in 80 CRISPR screens.
DR   ChiTaRS; Neu1; mouse.
DR   PRO; PR:O35657; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   RNAct; O35657; protein.
DR   Bgee; ENSMUSG00000007038; Expressed in right kidney and 230 other tissues.
DR   ExpressionAtlas; O35657; baseline and differential.
DR   Genevisible; O35657; MM.
DR   GO; GO:0030054; C:cell junction; ISO:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0043202; C:lysosomal lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016997; F:alpha-sialidase activity; ISO:MGI.
DR   GO; GO:0052794; F:exo-alpha-(2->3)-sialidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052796; F:exo-alpha-(2->8)-sialidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004308; F:exo-alpha-sialidase activity; IDA:MGI.
DR   GO; GO:0006689; P:ganglioside catabolic process; IBA:GO_Central.
DR   GO; GO:0009313; P:oligosaccharide catabolic process; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISO:MGI.
DR   GO; GO:2000291; P:regulation of myoblast proliferation; ISO:MGI.
DR   InterPro; IPR011040; Sialidase.
DR   InterPro; IPR026856; Sialidase_fam.
DR   InterPro; IPR036278; Sialidase_sf.
DR   PANTHER; PTHR10628; PTHR10628; 1.
DR   Pfam; PF13088; BNR_2; 1.
DR   SUPFAM; SSF50939; SSF50939; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Cell membrane; Cytoplasmic vesicle; Glycoprotein;
KW   Glycosidase; Hydrolase; Lipid degradation; Lipid metabolism; Lysosome;
KW   Membrane; Phosphoprotein; Reference proteome; Repeat; Signal.
FT   SIGNAL          1..41
FT                   /evidence="ECO:0000255"
FT   CHAIN           42..409
FT                   /note="Sialidase-1"
FT                   /id="PRO_0000012027"
FT   REPEAT          106..117
FT                   /note="BNR 1"
FT   REPEAT          166..177
FT                   /note="BNR 2"
FT   REPEAT          225..236
FT                   /note="BNR 3"
FT   REPEAT          341..352
FT                   /note="BNR 4"
FT   MOTIF           71..74
FT                   /note="FRIP motif"
FT   MOTIF           406..409
FT                   /note="Internalization signal"
FT   ACT_SITE        97
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        258
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        364
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        388
FT                   /evidence="ECO:0000255"
FT   BINDING         72
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         91
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         258
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         274
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         335
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        180
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        346
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         209
FT                   /note="L -> I (reduced activity)"
FT                   /evidence="ECO:0000269|PubMed:9425240"
FT   CONFLICT        107
FT                   /note="R -> K (in Ref. 2; AAC53536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        113
FT                   /note="S -> C (in Ref. 2; AAC53536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        117..121
FT                   /note="STAFI -> PTGFM (in Ref. 2; AAC53536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        172..173
FT                   /note="GI -> AF (in Ref. 2; AAC53536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="F -> L (in Ref. 2; AAC53536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        351
FT                   /note="Q -> L (in Ref. 4; AAH04666)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   409 AA;  44591 MW;  416BFD5BE27B8893 CRC64;
     MVGADPTRPR GPLSYWAGRR GQGLAAIFLL LVSAAESEAR AEDDFSLVQP LVTMEQLLWV
     SGKQIGSVDT FRIPLITATP RGTLLAFAEA RKKSASDEGA KFIAMRRSTD QGSTWSSTAF
     IVDDGEASDG LNLGAVVNDV DTGIVFLIYT LCAHKVNCQV ASTMLVWSKD DGISWSPPRN
     LSVDIGTEMF APGPGSGIQK QREPGKGRLI VCGHGTLERD GVFCLLSDDH GASWHYGTGV
     SGIPFGQPKH DHDFNPDECQ PYELPDGSVI INARNQNNYH CRCRIVLRSY DACDTLRPRD
     VTFDPELVDP VVAAGALATS SGIVFFSNPA HPEFRVNLTL RWSFSNGTSW QKERVQVWPG
     PSGYSSLTAL ENSTDGKKQP PQLFVLYEKG LNRYTESISM VKISVYGTL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024